CI Investments Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.85M | Sell |
13,128
-17,886
| -58% | -$7.96M | 0.02% | 287 |
|
|
2025
Q1 | $15M | Sell |
31,014
-4,854
| -14% | -$2.35M | 0.06% | 188 |
|
|
2024
Q4 | $14.4M | Sell |
35,868
-18,058
| -33% | -$7.27M | 0.05% | 200 |
|
|
2024
Q3 | $25.1M | Buy |
53,926
+40,498
| +302% | +$18.8M | 0.1% | 156 |
|
|
2024
Q2 | $6.29M | Buy |
13,428
+3,640
| +37% | +$1.71M | 0.02% | 258 |
|
|
2024
Q1 | $4.09M | Buy |
9,788
+3,025
| +45% | +$1.26M | 0.02% | 302 |
|
|
2023
Q4 | $2.75M | Sell |
6,763
-950
| -12% | -$387K | 0.01% | 307 |
|
|
2023
Q3 | $2.68M | Sell |
7,713
-512
| -6% | -$178K | 0.02% | 304 |
|
|
2023
Q2 | $2.9M | Sell |
8,225
-1,226
| -13% | -$432K | 0.01% | 306 |
|
|
2023
Q1 | $2.98M | Buy |
9,451
+1,737
| +23% | +$547K | 0.02% | 301 |
|
|
2022
Q4 | $2.23M | Buy |
7,714
+350
| +5% | +$101K | 0.01% | 321 |
|
|
2022
Q3 | $2.13M | Buy |
7,364
+1,701
| +30% | +$492K | 0.01% | 331 |
|
|
2022
Q2 | $1.6M | Sell |
5,663
-777
| -12% | -$219K | 0.01% | 352 |
|
|
2022
Q1 | $1.68M | Buy |
6,440
+551
| +9% | +$144K | 0.01% | 392 |
|
|
2021
Q4 | $1.29M | Buy |
5,889
+230
| +4% | +$50.5K | ﹤0.01% | 421 |
|
|
2021
Q3 | $1.03M | Buy |
5,659
+1,492
| +36% | +$271K | ﹤0.01% | 455 |
|
|
2021
Q2 | $840K | Sell |
4,167
-1,728
| -29% | -$348K | ﹤0.01% | 496 |
|
|
2021
Q1 | $1.27M | Buy |
5,895
+1,697
| +40% | +$365K | 0.01% | 374 |
|
|
2020
Q4 | $992K | Sell |
4,198
-91
| -2% | -$21.5K | ﹤0.01% | 389 |
|
|
2020
Q3 | $1.17M | Sell |
4,289
-227
| -5% | -$61.8K | 0.01% | 348 |
|
|
2020
Q2 | $1.31M | Buy |
4,516
+679
| +18% | +$197K | 0.01% | 335 |
|
|
2020
Q1 | $913K | Buy |
3,837
+2,720
| +244% | +$647K | 0.01% | 356 |
|
|
2019
Q4 | $245K | Buy |
1,117
+1,000
| +855% | +$219K | ﹤0.01% | 545 |
|
|
2019
Q3 | $20K | Buy |
+117
| New | +$20K | ﹤0.01% | 574 |
|
|
2019
Q1 | – | Sell |
-700
| Closed | -$116K | – | 366 |
|
|
2018
Q4 | $116K | Buy |
+700
| New | +$116K | ﹤0.01% | 300 |
|